The Neuromodulation Devices and Implantable Infusion Pumps market was valued at US$ xx in 2023. The market for Neuromodulation Devices and Implantable Infusion Pumps is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue. The report offers detailed coverage of Neuromodulation Devices and Implantable Infusion Pumps industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Neuromodulation Devices and Implantable Infusion Pumps by geography. The report splits the market size, by volume and value, on the basis of application type and geography. In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Neuromodulation Devices and Implantable Infusion Pumps market are discussed. The market is segmented by types: Spinal Cord Stimulation Deep Brain Stimulation Sacral Nerve Stimulation Vagal Nerve Stimulation Gastric Stimulation Transcranial magnetic Stimulation Transcutaneous Electrical Stimulation Other It can be also divided by applications: Parkinson's disease Epilepsy Pain Other And this report covers the historical situation, present status and the future prospects of the global Neuromodulation Devices and Implantable Infusion Pumps market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America. Finally, the report provides detailed profile and data information analysis of leading company. Medtronic Boston Scientific Corporation Abbott Synapse Biomedical Nevro Corporation Neuropace Cyberonics Autonomic Technologies Avery Biomedical Greatbatch Medical Report Includes: - xx data tables and xx additional tables - An overview of global Neuromodulation Devices and Implantable Infusion Pumps market - An detailed key players analysis across regions - Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031 - Insights into regulatory and environmental developments - Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Neuromodulation Devices and Implantable Infusion Pumps market - Profiles of major players in the industry, including Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation..... Research objectives To study and analyze the global Neuromodulation Devices and Implantable Infusion Pumps consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031. To understand the structure of Neuromodulation Devices and Implantable Infusion Pumps market by identifying its various subsegments. Focuses on the key global Neuromodulation Devices and Implantable Infusion Pumps manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years. To analyze the Neuromodulation Devices and Implantable Infusion Pumps with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the consumption of Neuromodulation Devices and Implantable Infusion Pumps submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents Global Neuromodulation Devices and Implantable Infusion Pumps Market Report 2024, Forecast to 2031 1 Scope of the Study 1.1 Neuromodulation Devices and Implantable Infusion Pumps Introduction 1.2 Research Programs 1.3 Analysis of Macroeconomic Indicators 1.4 Years Considered 1.5 Methodology 1.6 Data Source 1.7 Research Objectives 2 Neuromodulation Devices and Implantable Infusion Pumps Industry Overview 2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (Million USD) Comparison by Regions (2024-2031) 2.1.1 Neuromodulation Devices and Implantable Infusion Pumps Global Main Region Market Analysis 2.2 Market Analysis by Type 2.2.1 Spinal Cord Stimulation 2.2.2 Deep Brain Stimulation 2.2.3 Sacral Nerve Stimulation 2.2.4 Vagal Nerve Stimulation 2.2.5 Gastric Stimulation 2.2.6 Transcranial magnetic Stimulation 2.2.7 Transcutaneous Electrical Stimulation 2.2.8 Other 2.3 Market Analysis by Application 2.3.1 Parkinson's disease 2.3.2 Epilepsy 2.3.3 Pain 2.3.4 Other 2.4 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue, Sales and Market Share by Manufacturer 2.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Manufacturer (2019-2023) 2.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Manufacturer (2019-2023) 2.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Industry Concentration Ratio (CR5 and HHI) 2.4.4 Top 5 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share 2.4.5 Top 10 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share 2.4.6 Date of Key Manufacturers Enter into Neuromodulation Devices and Implantable Infusion Pumps Market 2.4.7 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Offered 2.4.8 Mergers & Acquisitions Planning 2.5 Neuromodulation Devices and Implantable Infusion Pumps Historical Development Overview 2.6 Market Dynamics 2.6.1 Market Opportunities 2.6.2 Market Risk 2.6.3 Market Driving Force 2.6.4 Porter's Five Forces Analysis 2.7 Coronavirus Disease 2019 (Covid-19): Neuromodulation Devices and Implantable Infusion Pumps Industry Impact 2.7.1 How the Covid-19 is Affecting the Neuromodulation Devices and Implantable Infusion Pumps Industry 2.7.2 Neuromodulation Devices and Implantable Infusion Pumps Business Impact Assessment - Covid-19 2.7.3 Market Trends and Neuromodulation Devices and Implantable Infusion Pumps Potential Opportunities in the COVID-19 Landscape 2.7.4 Measures / Proposal against Covid-19 3 Related Market Analysis 3.1 Related Market Overview 3.2 Macro Analysis of Upstream Markets 3.3 Key Players in Related Markets 3.4 Related Markets Trend Analysis 4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Categorized by Regions 4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Regions 4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Regions (2019-2023) 4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Regions (2019-2023) 4.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 4.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 4.4 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 4.5 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 5 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size Categorized by Countries 5.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Countries 5.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2019-2023) 5.1.2 Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 5.1.3 UK Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 5.1.4 France Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 5.1.5 Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 5.1.6 Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 5.1.7 Spain Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 5.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) by Manufacturers (2019-2023) 5.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2019-2023) 5.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2019-2023) 6 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size Categorized by Countries 6.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Countries 6.1.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2019-2023) 6.1.2 China Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 6.1.3 Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 6.1.4 Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 6.1.5 India Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 6.1.6 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 6.1.7 Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 6.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) by Players (2019-2023) 6.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2019-2023) 6.4 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2019-2023) 7 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size Categorized by Countries 7.1 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Countries 7.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2019-2023) 7.1.2 United States Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 7.1.3 Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 7.1.4 Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 7.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) by Players (2019-2023) 7.3 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2019-2023) 7.4 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2019-2023) 8 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size Categorized by Countries 8.1 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Countries 8.1.1 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2019-2023) 8.1.2 Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 8.2 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) by Players (2019-2023) 8.3 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2019-2023) 8.4 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2019-2023) 9 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size Categorized by Countries 9.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Countries 9.1.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2019-2023) 9.1.2 GCC Countries Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 9.1.3 Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 9.1.4 Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 9.1.5 South Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2019-2023) 9.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) by Players (2019-2023) 9.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2019-2023) 9.4 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2019-2023) 10 Global Neuromodulation Devices and Implantable Infusion Pumps Market Segment by Type 10.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2019-2023) 10.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Type (2024-2031) 10.3 Spinal Cord Stimulation Revenue Growth Rate 10.4 Deep Brain Stimulation Revenue Growth Rate 10.5 Sacral Nerve Stimulation Revenue Growth Rate 10.6 Vagal Nerve Stimulation Revenue Growth Rate 10.7 Gastric Stimulation Revenue Growth Rate 10.8 Transcranial magnetic Stimulation Revenue Growth Rate 10.9 Transcutaneous Electrical Stimulation Revenue Growth Rate 10.10 Other Revenue Growth Rate 11 Global Neuromodulation Devices and Implantable Infusion Pumps Market Segment by Application 11.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2019-2023) 11.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Application (2024-2031) 11.3 Parkinson's disease Revenue Growth Rate (2015-2025) 11.4 Epilepsy Revenue Growth Rate (2015-2025) 11.5 Pain Revenue Growth Rate (2015-2025) 11.6 Other Revenue Growth Rate (2015-2025) 12 Market Forecast for Neuromodulation Devices and Implantable Infusion Pumps 12.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast (2024-2031) 12.2 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Regions (2024-2031) 12.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Forecast (2024-2031) 12.4 APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Forecast (2024-2031) 12.5 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Forecast (2024-2031) 12.6 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Forecast (2024-2031) 12.7 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Forecast (2024-2031) 13 Analysis of Neuromodulation Devices and Implantable Infusion Pumps Industry Key Vendors 13.1 Medtronic 13.1.1 Company Details 13.1.2 Product Information 13.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Revenue and Gross Margin (2019-2023) 13.1.4 Main Business Overview 13.1.5 Medtronic News 13.2 Boston Scientific Corporation 13.2.1 Company Details 13.2.2 Product Information 13.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue and Gross Margin (2019-2023) 13.2.4 Main Business Overview 13.2.5 Boston Scientific Corporation News 13.3 Abbott 13.3.1 Company Details 13.3.2 Product Information 13.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Revenue and Gross Margin (2019-2023) 13.3.4 Main Business Overview 13.3.5 Abbott News 13.4 Synapse Biomedical 13.4.1 Company Details 13.4.2 Product Information 13.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue and Gross Margin (2019-2023) 13.4.4 Main Business Overview 13.4.5 Synapse Biomedical News 13.5 Nevro Corporation 13.5.1 Company Details 13.5.2 Product Information 13.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue and Gross Margin (2019-2023) 13.5.4 Main Business Overview 13.5.5 Nevro Corporation News 13.6 Neuropace 13.6.1 Company Details 13.6.2 Product Information 13.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Revenue and Gross Margin (2019-2023) 13.6.4 Main Business Overview 13.6.5 Neuropace News 13.7 Cyberonics 13.7.1 Company Details 13.7.2 Product Information 13.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Revenue and Gross Margin (2019-2023) 13.7.4 Main Business Overview 13.7.5 Cyberonics News 13.8 Autonomic Technologies 13.8.1 Company Details 13.8.2 Product Information 13.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Revenue and Gross Margin (2019-2023) 13.8.4 Main Business Overview 13.8.5 Autonomic Technologies News 13.9 Avery Biomedical 13.9.1 Company Details 13.9.2 Product Information 13.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue and Gross Margin (2019-2023) 13.9.4 Main Business Overview 13.9.5 Avery Biomedical News 13.10 Greatbatch Medical 13.10.1 Company Details 13.10.2 Product Information 13.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue and Gross Margin (2019-2023) 13.10.4 Main Business Overview 13.10.5 Greatbatch Medical News 14 Research Findings and Conclusion 15 Appendix